From: Evaluation of safety tool for ambulatory leprosy patients at risk of adverse outcome
Patient Characteristics | Pre-implementation (n = 8) | Post-implementation (n = 9) |
---|---|---|
Age, years, median (range) | 17 (3–81 yrs) | 50 (26–73 yrs) |
Male to Female Ratio | 3: 5 | 7: 2 |
Region of Acquisition | ||
Indian sub-continent | 7 (87.5%) | 4 (44.4%) |
Southeast Asia | 1 (12.5%) | 4 (44.4%) |
Africa | 0 | 1 (11.1%) |
Paucibacillarya Leprosy | 7 (87.5%) | 9 (100%) |
Multibacillaryb Leprosy | 1 (12.5%) | 0 |
Occurrence of Reactionc | ||
At presentation | 1 (12.5) | 5 (55.6%) |
During treatment | 1 (12.5%) | 8 (88.9%) |
Following treatment | 0 | 1 (11.1%) |
Loss to follow-up | 5 (62.5%) | 0 |